Cyprus Nominee Directors & ATAD 3 Substance (2026)

Cyprus has long been a structuring jurisdiction where nominee directorship was the cheap, default arrangement — a name on the corporate register, a signature in the minute book, €1,000 a year. That model is no longer fit for purpose. The OECD's BEPS work, the EU's ATAD 2, the in-flight ATAD 3 "Unshell" Directive, and an evolving Cyprus Tax Department practice on management and control have together raised the bar on what a Cyprus company has to look like to be respected as Cyprus-tax-resident and entitled to its treaty and EU directive benefits.

This article explains where the line now sits in 2026: what a nominee director actually is and is not, where ATAD 3 stands in the Council negotiations, who the gateway test catches, what the three substance indicators require in practice, what an independent director costs versus a nominee, and which structures still legitimately work with a nominee in the mix.

What a nominee director actually is

A nominee director is a person — usually an employee of a corporate-services firm — who is appointed to the board of a Cyprus company on behalf of the beneficial owner. The nominee is the registered director at the Department of Registrar of Companies; the beneficial owner controls the company in practice, typically through a declaration of trust and a written instructions arrangement. The model is permitted under the Companies Law Cap. 113 and regulated under the Cyprus AML framework, which obliges the nominee's service provider to maintain full KYC, UBO and source-of-funds files on the beneficial owner.

Critically, "nominee" is a commercial label, not a legal status under the Companies Law. A nominee director carries all the statutory duties of any other director: fiduciary duty to the company, duty of care, duty under section 174 to act in good faith, liability for unlawful dividends, wrongful trading exposure, and personal liability for unpaid VAT and PAYE in egregious cases. This is part of why the price has moved upward as the risk has risen.

Why nominees are still used in Cyprus

There are three distinct reasons clients ask for nominees, and only one of them is now problematic:

1. Privacy.The UBO register went semi-public after the CJEU's ruling and Cyprus' subsequent recalibration; see our note on Cyprus UBO register privacy in 2026. A nominee keeps the beneficial owner's name off the public-facing Registrar search, but does not — and cannot — hide the owner from regulated counterparties.
2. Administrative convenience. A locally-resident nominee can sign routine resolutions, attend the Registrar, and act as the contact for the corporate secretary and accountant. This is benign and continues to be a legitimate use case.
3. Tax residency on the cheap. Historically, some structures used a nominee as the sole Cyprus director to claim management-and-control in Cyprus. This is the use case that ATAD 3 and modern Cyprus practice are designed to neutralise.

ATAD 3 in 2026: where the file stands

The European Commission proposed Directive COM(2021) 565 — formally known as the Directive laying down rules to prevent the misuse of shell entities for tax purposes, and informally called ATAD 3 or the Unshell Directive — in December 2021. The original target date for transposition was 2024, with effect from 2025. That timeline has slipped repeatedly.

As of mid-2026 the file remains under Council negotiation. The principal sticking points have been: (i) the breadth of the gateway test, which catches a large universe of legitimate holding companies; (ii) the operation of the look-through mechanism vis-à-vis Member States with favourable participation exemptions (Cyprus, Luxembourg, the Netherlands, Ireland, Malta); (iii) the interaction with existing CFC rules under ATAD 1 and ATAD 2; and (iv) data-protection concerns over the exchange-of- information obligations. Several recent Council compromise texts have narrowed scope and softened the look-through to a deeming approach, but political agreement has not yet been reached.

The gateway test — who gets caught

The Unshell Directive applies a cumulative three-limb gateway. A Cyprus company is presumed "at risk" of being a shell and triggers the enhanced reporting obligations if, in each of the previous two tax years, all three of the following are true:

Several carve-outs apply: listed companies, regulated financial undertakings, certain holding companies whose shareholders and operating subsidiaries are in the same Member State, and undertakings with at least five full-time-equivalent own employees exclusively performing the income-generating activities. The carve-outs matter — many legitimate Cyprus structures land outside the gateway altogether.

The three substance indicators

A company that crosses all three gateways must self-declare in its tax return and provide evidence on three minimum substance indicators. Meeting all three rebuts the shell presumption; failing one or more makes the company an "undertaking at risk" and triggers the consequences in the next section.

Indicator 1: Premises

• Own premises in Cyprus, or premises exclusively available to the undertaking.
• A shared serviced-office desk used by twenty other companies is not enough.
• A dedicated lease, with the company's name on the door and on utility bills, satisfies the indicator.

Indicator 2: EU bank account

• At least one active and own bank account or e-money account in the EU.
• "Through which the relevant income is received" — the account must actually move the money, not exist dormant.
• See our comparison of Cyprus EMI vs bank account in 2026 for the practical choice.

Indicator 3: Director or employees

This is the indicator the nominee-only model fails. It requires either:

• At least one director who is: tax-resident in Cyprus (or in close geographical proximity that is compatible with proper management); qualified and authorised to take decisions in relation to the activities that generate the relevant income; actively and independently using that authority; AND not a director (or equivalent) of an unreasonable number of unrelated undertakings; AND not an employee of an unrelated enterprise and not providing director services as a commodity service.
• OR a majority of the FTE employees tax-resident in Cyprus, qualified to carry out the activities that generate the relevant income.

The two italicised phrases — "unreasonable number" and "effectively and independently" — are the directive's direct attack on the lone-nominee model. A nominee who is also a director of eighty other unrelated Cyprus companies, supplied as a commodity by a corporate-services firm, will not satisfy this indicator regardless of their personal qualifications.

Consequences of failing the test

If a Cyprus company is found to be a shell under ATAD 3 (or, in 2026, is treated as substance-deficient by counterparty tax authorities operating in the spirit of the directive), the consequences are severe:

1. No tax residency certificate, or a certificate that discloses the shell finding. Without a clean TRC, the Cyprus company cannot claim treaty benefits in source countries.
2. Loss of EU directive benefits. The Parent-Subsidiary Directive (0% on intra-EU dividends) and the Interest-and-Royalties Directive (0% on intra-EU interest and royalties) cease to apply. Source-state withholding tax is imposed at the treaty rate or the domestic rate.
3. Look-through to the shareholder. Income is taxed in the source state as if paid directly to the shareholder. Where the shareholder is in a high-tax jurisdiction, the cost can be material. See also our CFC rules guide for the companion shareholder-level overlay.
4. Exchange of information. The Cyprus authorities exchange information about the shell finding with all relevant Member States, which can prompt audits elsewhere.
5. Bank account closure. Cyprus banks, applying their own risk frameworks, frequently close accounts of entities flagged as substance-deficient.
6. DAC6 / DAC7 disclosure. The arrangement may itself be reportable; see our note on DAC6 and DAC7 in 2026.

Cost: nominee vs independent director

The economics drive most of the bad decisions in this space. Founders compare a €1,500 nominee against an €12,000 independent director and instinctively pick the nominee. The correct comparison is between the annual saving and the expected loss when treaty benefits or directive relief is denied on a single dividend, interest or royalty stream.

When nominee + substance kit still works

The nominee model is not dead. It continues to be appropriate where:

• The company is actively trading — operating revenue well above the 35% non-passive threshold — and therefore outside the gateway test entirely.
• The company has at least one independent Cyprus-resident director with real decision-making authority, with the nominee acting as an additional administrative director rather than the sole anchor.
• The company is in a carved-out category: listed, regulated financial institution, UCITS, pension fund, securitisation vehicle, or pure intra-Member-State holding.
• The company has sufficient FTE Cyprus employees — for most holding structures, two to three substantive hires in Cyprus satisfy the FTE limb of indicator 3.
• The use case is purely commercial privacy rather than tax residency — for instance, a UK-resident sole shareholder of a UK-tax-resident Cyprus company who uses a nominee just to keep their name off the public register.

When the model fails and you need a real director

The model reliably fails — and a qualified independent director becomes essential — in the following situations:

• Passive holding company with foreign-source dividends and a foreign-resident UBO, where treaty / directive benefits depend on Cyprus tax residency.
• IP-licensing vehicleclaiming the IP Box without Cyprus R&D employees — see our IP Box guide.
• Intra-group financing company relying on the Interest-and-Royalties Directive or a tax treaty to clear withholding tax on inbound interest. The transfer-pricing framework in our 2026 TP guide assumes Cyprus management is real.
• Crypto / CASP entity regulated under MiCA — see CASP / MiCA licensing — where the regulator requires senior management physically in Cyprus.
• Trust or family-office vehicle — see Cyprus international trusts — where trustee governance requires real Cyprus management.

Worked example: a passive holding co

Consider "HoldCo Limited", a Cyprus private company set up in 2023 by a UAE-resident founder to hold shares in three EU subsidiaries (Germany, the Netherlands and Spain). HoldCo's only income is dividends of €4m per year. Its only director is a single nominee supplied by a Cyprus corporate-services firm, who is also a director of approximately 60 other unrelated companies. The accounting and tax work is outsourced to that same firm.

Gateway analysis:

• Passive income: 100% > 65%. Limb 1 crossed.
• Cross-border: 100% of income is from foreign subsidiaries. Limb 2 crossed.
• Outsourced administration: yes. Limb 3 crossed.

Substance indicators:

• Premises: shared serviced address. Likely fails.
• EU bank account: passive Cyprus bank account, dividends flow through it. Probably passes.
• Qualified director: nominee with 60 unrelated directorships, decisions taken in Dubai. Fails — "unreasonable number" and not "effectively and independently".

Outcome: under the directive, HoldCo would be an undertaking at risk. Germany, Netherlands and Spain would deny the Parent-Subsidiary Directive and apply domestic withholding tax (5%-25% depending on jurisdiction). On €4m of dividends, the exposure is €200,000-€1,000,000 per year. Today, without the directive in force, the same outcome is increasingly being reached on the basis of beneficial-ownership analysis under treaty principles.

2026 substance compliance checklist

For any cross-border Cyprus passive structure, audit yourself annually against the following:

1. Dedicated leased premises in Cyprus, in the company's name, with utility bills.
2. Cyprus bank or EU EMI account in the company's name through which the relevant income demonstrably flows.
3. At least one Cyprus tax-resident director who is qualified, who holds a small number of unrelated directorships, who attends physically-held board meetings, who is named on the bank mandate, and who signs material contracts.
4. Minuted quarterly (at minimum) board meetings physically held in Cyprus, with material agenda items decided there.
5. Where possible, at least one Cyprus-resident employee performing income-generating or supporting functions, on PAYE — see hiring your first employee in Cyprus.
6. Compliant transfer-pricing file for all intra-group flows.
7. Annual review of the company's position against the ATAD 3 gateway test (as currently drafted) and against domestic management-and-control jurisprudence.
8. A current tax-residency certificate, supported by the documentary evidence above so that it survives counterparty scrutiny.
9. A documented disclosure assessment under DAC6 / DAC7.
10. Clear UBO position on file, consistent with the public register and any nominee declaration of trust — see our UBO register privacy guide.

How to upgrade a thin structure

If your current Cyprus structure is too thin, the upgrade path in 2026 looks like this:

1. Diagnose. Run the gateway test on the last two financial years. Identify which substance indicators are weak.
2. Premises. Move from a shared address to a dedicated lease. The cost differential is modest relative to the risk.
3. Director upgrade.Replace or supplement the nominee with a qualified independent Cyprus-resident director who carries a manageable caseload of unrelated directorships and is willing to be named on bank mandates and material contracts. Document the director's qualifications and decision-making process.
4. Bank account. If the account is in fact dormant — income arrives in a foreign account and only filters through Cyprus on paper — re-route the cash flow so the Cyprus account is actually used.
5. Employees. Where activity warrants, hire at least one Cyprus-resident employee on PAYE. This is often cheaper than founders assume given the 50% expat exemption and the favourable social-insurance position covered in our GHS / GeSY note.
6. Governance. Move material decisions (distributions, financing, treaty claims, IP licensing) to physically-held Cyprus board meetings with minuted resolutions.
7. Advance certainty. Where the value at stake justifies it, obtain a binding advance tax ruling. See our guide to Cyprus tax rulings in 2026.